{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:08:24Z","timestamp":1789085304218,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; aims<\/jats:title>\n                    <jats:p>Coinfection of hepatitis B virus (HBV) with hepatitis D virus (HDV) may exacerbate liver injury, particularly in resource-limited settings. In Ghana, data on HDV and OBI prevalence, as well as their hepatic impact, remain sparse. This study aimed to determine the prevalence of HDV and OBI using real-time PCR and evaluate their effects on liver-related biomarkers in patients at Bimbila Hospital, Northern Ghana.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study at Bimbilla Hospital, Northern Ghana, between May and December 2024, recruiting 60 consented patients with Hepatitis B Surface Antigen positive and 60 patients with HBsAg-negative status. HBV serology (HBsAg, HBeAg, anti-HBs, total anti-HBc) was performed using a 5-in-1 panel. HBV DNA and HDV RNA were detected by real-time PCR. HDV prevalence was determined among HBsAg-positive participants by real-time PCR detection of HDV RNA, while OBI prevalence was determined among HBsAg-negative participants by the presence of detectable HBV DNA using real-time PCR following serological screening. Liver biochemical, haematological, and inflammatory markers were measured, and fibrotic indices (APRI, FIB-4, PLR, GLR) were computed. Data were analysed using SPSS 26 and GraphPad Prism version 8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HDV RNA was detected in 11\/60 HBsAg-positive participants (18.3%, 95% CI 10.66\u201329.9). OBI occurred in 5\/60 HBsAg-negative participants (8.3%, 95% CI 3.6\u201318.1). Compared to HBV-monoinfected individuals, HBV\/HDV-coinfected patients had higher Gamma-Glutamyltransferase (GGT;45.0 vs. 37.0 IU\/L,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), lower Albumin\/Globulin Ratio (A\/G;1.21 vs. 1.34,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), elevated Granulocyte-to-Lymphocyte Ratio (GLR; 2.60 vs. 1.87,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), and higher Platelet-to-Lymphocyte Ratio (PLR; 143.00 vs. 89.87,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). HBV\/HDV coinfected patients also showed elevated Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), total bilirubin (TBIL), IBL, AST\/ALT ratio (de Ritis), and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) scores compared to those with OBI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In Northern Ghana, HDV coinfection may be associated with significant alterations in GGT, AST, ALT, bilirubin levels, de-Ritis ratio, APRI, PLR, and GLR, with concurrent reduction in the A\/G ratio, suggesting significant hepatic and inflammatory disturbances, whereas OBI may show no comparable biomarker alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13881-8","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:48:03Z","timestamp":1782384483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and biomarker profiles of HBV\/HDV coinfection and occult HBV infection among patients attending Bimbilla Hospital, Northern Ghana"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3757-2569","authenticated-orcid":false,"given":"Eric Nana Yaw","family":"Nyarko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justice","family":"Kumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliu","family":"Issahaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer Kwabena","family":"Amakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-8505","authenticated-orcid":false,"given":"Manfred","family":"Anim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildred","family":"Adusei-Poku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisa Akua","family":"Assan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Kwame","family":"Sraku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Adom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Kpabitey","family":"Lawer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abass","family":"Abdul-Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Kwaku","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Asare-Anane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Obirikorang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"6","key":"13881_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0234348","volume":"15","author":"J Abesig","year":"2020","unstructured":"Abesig J, Chen Y, Wang H, Mwekele F, Irene S, Wu XY. Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis. PLoS ONE. 2020;15(6):1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0234348. PubMed PMID: 32530945.","journal-title":"PLoS ONE"},{"issue":"January","key":"13881_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijregi.2023.01.009","volume":"6","author":"Sdogbey Efua","year":"2023","unstructured":"Efua Sdogbey, Delali V, Armah W. Seroprevalence of Hepatitis B virus infection and associated factors among health care workers in Southern Ghana. IJID Reg. 2023;6(January):84\u20139. https:\/\/doi.org\/10.1016\/j.ijregi.2023.01.009.","journal-title":"IJID Reg"},{"key":"13881_CR3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2147\/CLEP.S389853","volume":"14","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu Y, Zhao H, Wang G. Global patterns and trends in total burden of hepatitis B from 1990 to 2019 and predictions to 2030. Clin Epidemiol. 2022;14:1519. https:\/\/doi.org\/10.2147\/CLEP.S389853. PubMed PMID: 36540899.","journal-title":"Clin Epidemiol"},{"key":"13881_CR4","unstructured":"Mehta P, Grant LM, Reddivari AKR. Viral hepatitis. StatPearls. 2024 Mar. PubMed PMID: 32119436."},{"issue":"4","key":"13881_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/jvh.13800","volume":"30","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Yu ML, Yilmaz Y, Alswat KA, Buti M, Fernandez MIC, et al. Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry\u2122. J Viral Hepat. 2023;30(4):335\u201344. 10. 1111\/JVH.13800 PubMed PMID: 36601668.","journal-title":"J Viral Hepat"},{"issue":"29","key":"13881_CR6","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3748\/WJG.V28","volume":"28","author":"B Gnyawali","year":"2022","unstructured":"Gnyawali B, Pusateri A, Nickerson A, Jalil S, Mumtaz K. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World J Gastroenterol. 2022;28(29):3793. https:\/\/doi.org\/10.3748\/WJG.V28. I29.3793 PubMed PMID: 36157533.","journal-title":"World J Gastroenterol"},{"key":"13881_CR7","doi-asserted-by":"crossref","unstructured":"Agbozo WK, Dzudzor B, Nyarko ENY, Lartey-abrahams K, Mensah NA, Tachi K. Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghana- ian tertiary hospital. 2022;56(4).","DOI":"10.4314\/gmj.v56i4.4"},{"issue":"17","key":"13881_CR8","doi-asserted-by":"publisher","first-page":"e37097","DOI":"10.1016\/J.HELIYON.2024.E37097","volume":"10","author":"S Delghandi","year":"2024","unstructured":"Delghandi S, Raoufinia R, Shahtahmasbi S, Meshkat Z, Gouklani H, Gholoobi A. An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination. Heliyon. 2024;10(17):e37097. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E37097.","journal-title":"Heliyon"},{"issue":"2","key":"13881_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1478-3231.2011.02481.x","volume":"32","author":"Y Shi","year":"2012","unstructured":"Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, Chen Z. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int. 2012;32(2):231\u201340. https:\/\/doi.org\/10.1111\/J.1478-3231.2011.02481.X. PubMed PMID: 21745272.","journal-title":"Liver Int"},{"issue":"4","key":"13881_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","volume":"73","author":"LY Mak","year":"2020","unstructured":"Mak LY, Wong DKH, Pollicino T, Raimondo G, Hollinger FB, Yuen MF. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020;73(4):952\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.042. PubMed PMID: 32504662.","journal-title":"J Hepatol"},{"issue":"4","key":"13881_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2478\/JTIM-2024-0015\/PDF","volume":"12","author":"J Wu","year":"2024","unstructured":"Wu J, Wang H, Xiang Z, Jiang C, Xu Y, Zhai G, et al. Role of viral hepatitis in pregnancy and its triggering mechanism. J Transl Int Med. 2024;12(4):344\u201354. https:\/\/doi.org\/10.2478\/JTIM-2024-0015\/PDF.","journal-title":"J Transl Int Med"},{"issue":"1","key":"13881_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40249-024-01225-0\/FIGURES\/4","volume":"13","author":"C Li","year":"2024","unstructured":"Li C, Thapa D, Mi Q, Gao Y, Fu X. Disparities in hepatitis B virus healthcare service access among marginalised poor populations: a mixed-method systematic review. Infect Dis Poverty. 2024;13(1):1\u201331. https:\/\/doi.org\/10.1186\/S40249-024-01225-0\/FIGURES\/4. PubMed PMID: 39123232.","journal-title":"Infect Dis Poverty"},{"key":"13881_CR13","doi-asserted-by":"publisher","unstructured":"Saitta C, Pollicino T, Raimondo G. Occult hepatitis B virus infection: an update. Viruses. 2022;14(7). https:\/\/doi.org\/10.3390\/V14071504. PubMed PMID: 35891484.","DOI":"10.3390\/V14071504"},{"issue":"1","key":"13881_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-020-01376-0","volume":"17","author":"E Nyarko","year":"2020","unstructured":"Nyarko E, Obirikorang C, Owiredu WKBA, Adu EA, Acheampong E, Aidoo F, et al. NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population. Virol J. 2020;17(1):1\u20138. https:\/\/doi.org\/10.1186\/s12985-020-01376-0. PubMed PMID: 32620148.","journal-title":"Virol J"},{"issue":"1","key":"13881_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-023-06581","volume":"16","author":"ENY Nyarko","year":"2023","unstructured":"Nyarko ENY, Obirikorang C, Owiredu WKBA, Adu EA, Acheampong E. Assessment of the performance of haematological and non-invasive fibrotic indices for the monitoring of chronic HBV infection: a pilot study in a Ghanaian population. BMC Res Notes. 2023;16(1):1\u20138. https:\/\/doi.org\/10.1186\/s13104-023-06581-y. PubMed PMID: 37925465.","journal-title":"BMC Res Notes"},{"key":"13881_CR16","doi-asserted-by":"publisher","unstructured":"Kumar M, Pahuja S, Khare P, Kumar A. Current challenges and future perspectives of diagnosis of hepatitis B virus. Diagnostics. 2023;13(3):368. https:\/\/doi.org\/10.3390\/DIAGNOSTICS13030368.","DOI":"10.3390\/DIAGNOSTICS13030368"},{"key":"13881_CR17","doi-asserted-by":"publisher","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;121\u20136. https:\/\/doi.org\/10.4103\/0253-7176.116232. PubMed PMID: 24049221.","DOI":"10.4103\/0253-7176.116232"},{"issue":"3","key":"13881_CR18","doi-asserted-by":"publisher","first-page":"e0290917","DOI":"10.1371\/journal.pone.0290917","volume":"19","author":"B Dzudzor","year":"2024","unstructured":"Dzudzor B, Nsowah KK, Agyemang S, Vento S, Amarh V, Boima V, et al. Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana. PLoS ONE. 2024;19(3):e0290917. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0290917. PubMed PMID: 38437229.","journal-title":"PLoS ONE"},{"issue":"2","key":"13881_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","volume":"71","author":"G Raimondo","year":"2019","unstructured":"Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397\u2013408. https:\/\/doi.org\/10.1016\/J.JHEP.2019.03.034. PubMed PMID: 31004683.","journal-title":"J Hepatol"},{"key":"13881_CR20","unstructured":"Roboscreen Diagnostics. Instructions for use RoboGene HBV DNA quantification Kit 3.0 [Internet]. 2022 Jan. Available from: https:\/\/www.roboscreen.com."},{"issue":"1","key":"13881_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12889-024-21017-3\/FIGURES\/4","volume":"24","author":"OMA Akabuike","year":"2024","unstructured":"Akabuike OMA, Aworh MK, Uzoebo NL, Erwat J, Agukwe O, Ngong K, et al. Evaluating hepatitis B screening, prevalence, vaccination coverage, and linkage to care in Abuja, Nigeria: insights from a cross-sectional study. BMC Public Health. 2024;24(1):1\u201311. https:\/\/doi.org\/10.1186\/S12889-024-21017-3\/FIGURES\/4.","journal-title":"BMC Public Health"},{"issue":"1","key":"13881_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12985-025-02633-W\/TABLES\/5","volume":"22","author":"YM Larebo","year":"2025","unstructured":"Larebo YM, Anshebo AA, Behera SK, Gopalan N. Prevalence of hepatitis B virus infection and associated factors among adults intrafamilial household contacts attending antenatal care clinics in the Central Ethiopian region: from pregnant women index cases. Virol J. 2025;22(1):1\u201311. https:\/\/doi.org\/10.1186\/S12985-025-02633-W\/TABLES\/5.","journal-title":"Virol J"},{"issue":"7","key":"13881_CR23","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jiph.2023.05.003","volume":"16","author":"S Athalye","year":"2023","unstructured":"Athalye S, Khargekar N, Shinde S, Parmar T, Chavan S, Swamidurai G, et al. Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: Implications and perspective. J Infect Public Health. 2023;16(7):1109\u201314. https:\/\/doi.org\/10.1016\/J.JIPH.2023.05.003. PubMed PMID: 37224621.","journal-title":"J Infect Public Health"},{"issue":"10","key":"13881_CR24","first-page":"1452","volume":"26","author":"Y Yin","year":"2006","unstructured":"Yin Y, zhu, Chen X, wei, Li X, mao, Hou H, ying, Shi Z. jie. [Intrauterine HBV infection: risk factors and impact of HBV DNA]. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26(10):1452\u20134. PubMed PMID: 17062350.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"11","key":"13881_CR25","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1111\/liv.15390","volume":"42","author":"NN Tazinkeng","year":"2022","unstructured":"Tazinkeng NN, Teuwafeu DG, Asombang AW, Agbor VN, Bloom SM, Nkhoma AN, et al. Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study. Liver Int. 2022;42(11):2396\u2013402. 10. 1111\/LIV.15390 PubMed PMID: 35946051.","journal-title":"Liver Int"},{"issue":"5","key":"13881_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/oxfordjournals.aje.a009474","volume":"147","author":"FEA Martinson","year":"1998","unstructured":"Martinson FEA, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk Factors for Horizontal Transmission of Hepatitis B Virus in a Rural District in Ghana. Am J Epidemiol. 1998;147(5):478\u201387. 10.1093\/. OXFORDJOURNALS.AJE.A009474 PubMed PMID: 9525535.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"13881_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jceh.2017.05.010","volume":"7","author":"HN Luma","year":"2017","unstructured":"Luma HN, Eloumou SAFB, Okalla C, Donfack-Sontsa O, Koumitana R, Malongue A, et al. Prevalence and Characteristics of Hepatitis Delta Virus Infection in a Tertiary Hospital Setting in Cameroon. J Clin Exp Hepatol. 2017;7(4):334\u20139. https:\/\/doi.org\/10.1016\/j.jceh.2017.05.010.","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"13881_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/JCM.01822-10","volume":"49","author":"Y Foupouapouognigni","year":"2011","unstructured":"Foupouapouognigni Y, Noah DN, Sartre MT, Njouom R. High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon. J Clin Microbiol. 2011;49(3):1162\u20134. https:\/\/doi.org\/10.1128\/JCM.01822-10. PubMed PMID: 21209162.","journal-title":"J Clin Microbiol"},{"key":"13881_CR29","doi-asserted-by":"publisher","unstructured":"Butler EK, Rodgers MA, Coller KE, Barnaby D, Krilich E, Olivo A, et al. High prevalence of hepatitis delta virus in Cameroon. Sci Rep. 2018;8(1). https:\/\/doi.org\/10.1038\/s41598-018-30078-5. PubMed PMID: 30072752.","DOI":"10.1038\/s41598-018-30078-5"},{"key":"13881_CR30","doi-asserted-by":"publisher","unstructured":"Coffie PA, Tchounga BK, Bado G, Kabran M, Minta DK, Wandeler G, et al. Prevalence of hepatitis B and delta according to HIV-type: a multicountry cross-sectional survey in West Africa. BMC Infect Dis. 2017;17(1). https:\/\/doi.org\/10.1186\/s12879-017-2568-5. PubMed PMID: 28676076.","DOI":"10.1186\/s12879-017-2568-5"},{"issue":"6","key":"13881_CR31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/hep.28957","volume":"66","author":"X Chen","year":"2017","unstructured":"Chen X, Oidovsambuu O, Liu P, Grosely R, Elazar M, Winn VD, et al. A novel quantitative microarray antibody capture (Q-MAC) assay identifies an extremely high HDV prevalence amongst HBV infected Mongolians. Hepatology. 2017;66(6):1739. 10. 1002\/HEP.28957 PubMed PMID: 27880976.","journal-title":"Hepatology"},{"issue":"1 January","key":"13881_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0244507","volume":"16","author":"K Attiku","year":"2021","unstructured":"Attiku K, Bonney J, Agbosu E, Bonney E, Puplampu P, Ganu V, et al. Circulation of hepatitis delta virus and occult hepatitis B virus infection amongst HIV\/HBV coinfected patients in Korle-Bu, Ghana. PLoS ONE. 2021;16(1 January):1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0244507. PubMed PMID: 33411715.","journal-title":"PLoS ONE"},{"issue":"12","key":"13881_CR33","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.12998\/WJCC.V10","volume":"10","author":"DV Garbuzenko","year":"2022","unstructured":"Garbuzenko DV. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. World J Clin Cases. 2022;10(12):3662\u201376. https:\/\/doi.org\/10.12998\/WJCC.V10. I12.3662 PubMed PMID: 35647163.","journal-title":"World J Clin Cases"},{"key":"13881_CR34","doi-asserted-by":"publisher","unstructured":"Dandri M, Bertoletti A, L\u00fctgehetmann M. Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition [Internet]. https:\/\/doi.org\/10.1007\/s00281-021-00864-x\/Published.","DOI":"10.1007\/s00281-021-00864-x\/Published"},{"key":"13881_CR35","doi-asserted-by":"publisher","unstructured":"Bockmann JH, Allweiss L, Volmari A, da Fonseca Ara\u00fajo D, Kohsar M, Hyrina A, et al. Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3\u2009+\u2009CD4 T cells. JHEP Rep. 2025;7(3). https:\/\/doi.org\/10.1016\/j.jhepr.2024.101273.","DOI":"10.1016\/j.jhepr.2024.101273"},{"issue":"2","key":"13881_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jhep.2019.04.009","volume":"71","author":"J Dias","year":"2019","unstructured":"Dias J, Hengst J, Parrot T, Leeansyah E, Lunemann S, Malone DFG, et al. Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells. J Hepatol. 2019;71(2):301\u201312. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.009. PubMed PMID: 31100314.","journal-title":"J Hepatol"},{"issue":"5","key":"13881_CR37","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/hep.26203","volume":"57","author":"JE Everhart","year":"2013","unstructured":"Everhart JE, Wright EC. Association of \u03b3-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology. 2013;57(5):1725\u201333. https:\/\/doi.org\/10.1002\/hep.26203. PubMed PMID: 23258530.","journal-title":"Hepatology"},{"issue":"17","key":"13881_CR38","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.12998\/WJCC.V10.I17.5518","volume":"10","author":"GS Gherlan","year":"2022","unstructured":"Gherlan GS. Occult hepatitis B \u2014 the result of the host immune response interaction with different genomic expressions of the virus. World J Clin Cases. 2022;10(17):5518. https:\/\/doi.org\/10.12998\/WJCC.V10.I17.5518. PubMed PMID: 35979101.","journal-title":"World J Clin Cases"},{"issue":"3","key":"13881_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1515\/mr-2024-0022","volume":"4","author":"SA Hudu","year":"2024","unstructured":"Hudu SA, Shinkafi SH, Jimoh AO. A critical review of diagnostic and prognostic markers of chronic hepatitis B infection. Med Rev. 2024;4(3):225\u201334. https:\/\/doi.org\/10.1515\/mr-2024-0022.","journal-title":"Med Rev"},{"issue":"2","key":"13881_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cgh.2019.06","volume":"18","author":"DKH Wong","year":"2020","unstructured":"Wong DKH, Cheng SCY, Mak LLY, To EWP, Lo RCL, Cheung TT, et al. Among patients with undetectable hepatitis B surface antigen and hepatocellular carcinoma, a high proportion has integration of HBV DNA into hepatocyte DNA and no cirrhosis. Clin Gastroenterol Hepatol. 2020;18(2):449\u201356. https:\/\/doi.org\/10.1016\/j.cgh.2019.06.029. PubMed PMID: 31252193.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"13881_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4103\/0377-4929.142643","volume":"57","author":"M Rizvi","year":"2014","unstructured":"Rizvi M, Azam M, Sultan A, Shukla I, Malik A, Ajmal MR, et al. Prevalence of genotype D in chronic liver disease patients with occult HBV infection in northern region of India. Indian J Pathol Microbiol. 2014;57(4):537\u201341. https:\/\/doi.org\/10.4103\/0377-4929.142643. PubMed PMID: 25308003.","journal-title":"Indian J Pathol Microbiol"},{"key":"13881_CR42","doi-asserted-by":"publisher","unstructured":"Opaleye OO, Akanbi OA, Osundare FA, Wang B, Adesina O, Oluremi AS, et al. Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria. Virol J. 2021;18(1). https:\/\/doi.org\/10.1186\/s12985-021-01493-4. PubMed PMID: 33446224.","DOI":"10.1186\/s12985-021-01493-4"},{"key":"13881_CR43","unstructured":"Nwokediuko SC. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. J Clin Pract. 2009."},{"key":"13881_CR44","doi-asserted-by":"publisher","unstructured":"Jepkemei KB, Ochwoto M, Swidinsky K, Day J, Gebrebrhan H, McKinnon LR, et al. Characterisation of occult hepatitis B in highrisk populations in Kenya. PLoS ONE. 2020;15(5). https:\/\/doi.org\/10.1371\/journal.pone.0233727. PubMed PMID: 32463824.","DOI":"10.1371\/journal.pone.0233727"},{"key":"13881_CR45","doi-asserted-by":"publisher","unstructured":"Ayana DA, Mulu A, Mihret A, Seyoum B, Aseffa A, Howe R. Occult hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia. Sci Rep. 2020;10(1). https:\/\/doi.org\/10.1038\/s41598-020-79392-x. PubMed PMID: 33335238.","DOI":"10.1038\/s41598-020-79392-x"},{"issue":"5","key":"13881_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1179\/2047773214Y","volume":"108","author":"E Nna","year":"2014","unstructured":"Nna E, Mbamalu C, Ekejindu I. Occult hepatitis B viral infection among blood donors in South\u2013Eastern Nigeria. Pathog Glob Health. 2014;108(5):223\u20138. https:\/\/doi.org\/10.1179\/2047773214Y.0000000144. PubMed PMID: 24995918.","journal-title":"Pathog Glob Health"},{"key":"13881_CR47","doi-asserted-by":"publisher","unstructured":"Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, et al. Characterisation of occult hepatitis B virus infection among HIV positive patients in Cameroon. AIDS Res Ther. 2017;14(1). https:\/\/doi.org\/10.1186\/s12981-017-0136-0. PubMed PMID: 28270215.","DOI":"10.1186\/s12981-017-0136-0"},{"key":"13881_CR48","doi-asserted-by":"publisher","unstructured":"Anderson M, Phinius BB, Phakedi BK, Mudanga M, Bhebhe LN, Tlhabano GN, et al. Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-na\u00efve people living with HIV in Botswana. Front Microbiol. 2024;15. https:\/\/doi.org\/10.3389\/fmicb.2024.1342862.","DOI":"10.3389\/fmicb.2024.1342862"},{"key":"13881_CR49","unstructured":"Pollicino T, Raimondo G. Occult hepatitis B, infection \u201cOvert\u201d HBV infection overt HBV infection occult HBV infection occult HBV infection hepatology snapshot. J Hepatol. 2014."},{"key":"13881_CR50","doi-asserted-by":"publisher","unstructured":"de Almeida NAA, de Paula VS. Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: a literature review. J Appl Microbiol. John Wiley and Sons Inc; 2022. pp. 1616\u201335. https:\/\/doi.org\/10.1111\/jam.15351. PubMed PMID: 34724308.","DOI":"10.1111\/jam.15351"},{"issue":"12","key":"13881_CR51","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jiph.2022.11.008","volume":"15","author":"JLN Ondigui","year":"2022","unstructured":"Ondigui JLN, Kenmoe S, Kengne-Nd\u00e9 C, Ebogo-Belobo JT, Takuissu GR, Kenfack-Momo R, et al. Epidemiology of occult hepatitis B and C in Africa: a systematic review and meta-analysis. J Infect Public Health. 2022;15(12):1436\u201345. https:\/\/doi.org\/10.1016\/j.jiph.2022.11.008. PubMed PMID: 36395668.","journal-title":"J Infect Public Health"},{"key":"13881_CR52","doi-asserted-by":"crossref","unstructured":"Khalid E, Abrar A, Abdel Rahim MEH, Islam ME, Khalid E. Occult hepatitis B virus infection in Sudan: a systematic review and meta-analysis. JGH Open. 2020;4(5):800\u20137.","DOI":"10.1002\/jgh3.12411"},{"issue":"3","key":"13881_CR53","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/gut.46.3.420","volume":"46","author":"G Fattovich","year":"2000","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut. 2000;46(3):420\u20136. PubMed PMID: 10673308.","journal-title":"Gut"},{"key":"13881_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijid.2018.07.005","volume":"74","author":"S Coghill","year":"2018","unstructured":"Coghill S, McNamara J, Woods M, Hajkowicz K. Epidemiology and clinical outcomes of hepatitis delta (D) virus infection in Queensland, Australia. Int J Infect Dis. 2018;74:123\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2018.07.005. PubMed PMID: 30003953.","journal-title":"Int J Infect Dis"},{"issue":"S1","key":"13881_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.31481","volume":"73","author":"KJ Wangensteen","year":"2021","unstructured":"Wangensteen KJ, Chang KM. Multiple roles for hepatitis B and C viruses and the host in the development of hepatocellular carcinoma. Hepatology. 2021;73(S1):27\u201337. https:\/\/doi.org\/10.1002\/HEP.31481. PubMed PMID: 32737895.","journal-title":"Hepatology"},{"key":"13881_CR56","unstructured":"WHO. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection [Internet]. Geneva; 2024 Mar [cited 2024 Sep 5]. Available from: https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo."},{"key":"13881_CR57","doi-asserted-by":"publisher","unstructured":"Toy\u00e9 RM, Loureiro CL, Jaspe RC, Zoulim F, Pujol FH, Chemin I. The hepatitis B virus genotypes E to J: the overlooked genotypes. Microorganisms. Multidisciplinary Digital Publishing Institute (MDPI); 2023. https:\/\/doi.org\/10.3390\/microorganisms11081908.","DOI":"10.3390\/microorganisms11081908"},{"key":"13881_CR58","doi-asserted-by":"publisher","unstructured":"Cuenca-G\u00f3mez J\u00c1, Lozano-Serrano AB, Cabezas-Fern\u00e1ndez MT, Soriano-P\u00e9rez MJ, V\u00e1zquez-Villegas J, Est\u00e9vez-Escobar M, et al. Chronic hepatitis B genotype e in African migrants: response to nucleos(t)ide treatment in real clinical practice. BMC Infect Dis. 2018;18(1). https:\/\/doi.org\/10.1186\/s12879-018-3469-y. PubMed PMID: 30428845.","DOI":"10.1186\/s12879-018-3469-y"},{"issue":"4","key":"13881_CR59","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2478\/jtim-2023-0118","volume":"11","author":"Jae Hyug Choi","year":"2023","unstructured":"Hyug Choi J, Sook Jun M, Yong Jeon J, Kim H, Kyung Kim Y, Ho Jeon C, et al. Global lineage evolution pattern of sars-cov-2 in Africa, America, Europe, and Asia: A comparative analysis of variant clusters and their relevance across continents. J Transl Intern Med. 2023;11(4):350\u201362. https:\/\/doi.org\/10.2478\/JTIM-2023-0118.","journal-title":"Journal of Translational Internal Medicine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13881-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13881-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13881-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:29:29Z","timestamp":1789082969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13881-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13881"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13881-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the University of Ghana College of Health Sciences Ethical Protocol and Review Committee (ethical approval number: CHS-Et\/M.8-P5.9\/2023\u20132024). Written informed consent was obtained from all participants before they were allowed to participate in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1635"}}